In vitro genioglossus function is different in obese and non-obese patients with obstructive sleep apneaSource: Eur Respir J 2001; 18: Suppl. 33, 332s Year: 2001
Differences in levels of systemic inflammation markers between obese subjects with or without obstructive sleep apnea Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010
Triglyceride-glucose index in non-diabetic, non-obese patients with obstructive sleep apnoea Source: Virtual Congress 2021 – Pathophysiology and clinical consequences of obstructive sleep apnoea Year: 2021
Impact of obstructive sleep apnoea on insulin resistance in nonobese and obese children Source: Eur Respir J 2016; 47: 1152-1161 Year: 2016
Severity of sleep apnea and daytime hypoxemia do not significantly contribute to endothelial dysfunction in morbidly obese subjects Source: Annual Congress 2010 - Sleep apnoea: insights from basic and clinical research Year: 2010
The severity of sleep-disordered breathing is independently associated with increased peripheral leukocytes and neutrophils in overweight children and adolescents Source: Annual Congress 2007 - Sleep apnoea in childhood Year: 2007
Risk of obstructive sleep apnea and impaired glucose metabolism in non-diabetic subjects Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea Year: 2019
Chronic hypercapnia in morbidly obese patients with obstructive sleep apnea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005
The upper airway and obstructive sleep apnea in morbidly obese women Source: Eur Respir J 2004; 24: Suppl. 48, 119s Year: 2004
Relationship between upper airway and obstructive sleep apnea-hypopnea syndrome in morbidly obese women Source: Eur Respir J 2006; 28: Suppl. 50, 199s Year: 2006
Serum leptin levels in obese patients with severe obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 332s Year: 2004
Determinants of hypercapnia in obese obstructive sleep apnea (OSA) patients Source: Eur Respir J 2004; 24: Suppl. 48, 447s Year: 2004
Plasma total antioxidant status in obstructive sleep apnea men Source: Eur Respir J 2005; 26: Suppl. 49, 356s Year: 2005
Clinical predictors of obesity hypoventilation syndrome in morbidly obese subjects with obstructive sleep apnoea Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I Year: 2015
Obstructive sleep apnea in normal weight patients: characteristics and comparison with overweight and obese patients Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea Year: 2019
Gender difference on polysomnographic parameters of severely obese patients with obstructive sleep apnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 331s Year: 2007
Metabolic and inflammatory profile in obese and non obese children with obstructive breathing disorders Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011
Plasma adiponectin levels and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2004 - Systemic and metabolic effects from OSA Year: 2004
The effect of 12-month growth hormone treatment on obstructive sleep apnoea in abdominally obese men Source: Annual Congress 2008 - Alternatives for continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2008
Impact of obstructive sleep apnea and obesity on endothelial dysfunction in children Source: Virtual Congress 2020 – Respiratory physiology and sleep: from neonates to adults Year: 2020